Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#86 in Lund
#1,305 in Sweden
A1m Pharma Ab
Forward Citations = 4
6 inventors:
A1m Pharma Ab
% Expired Patents = 75.0
CIPO Patents = 1
EPO Patents = 5
Forward Citations = 4
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Bo Åkerström (3 out of 5 patents)
Stefan Hansson (3 out of 4 patents)
Magnus Gram (2 out of 2 patents)
4. Lena Wester Rosenlöf (1 out of 2 patents)
5. Martin Lennarth Olsson (1 out of 1 patent)
6. Bo Åkerstrom (1 out of 1 patent)
7. Bo Akerström (0 patent)
8. Bo Akerstroem (0 patent)
9. Lena ROSENLÖF (0 patent)
10. Bo Åkerström (0 patent)
4 patents:
Company Overview
A1M Pharma AB is a biopharmaceutical company that develops therapeutic proteins for the treatment of severe kidney damage and related conditions. With a focus on improving patient outcomes and addressing unmet medical needs, A1M Pharma aims to bring novel therapies to market that have the potential to make a significant impact on human health.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: A1m Pharma Ab. Retrieved from https://idiyas.com/company/a1m-pharma-ab
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]